Diabetes Disrupts Bile Acid Balance via Gut Microbiome, But Obesity Alone Does Not
A 492-person study finds prediabetes and T2D—not obesity alone—alter bile acid profiles and gut microbial metabolism in distinct, measurable ways.
Summary
Researchers analyzed bile acid (BA) profiles, gut microbiome composition, and serum metabolomics in 492 adults across metabolic phenotypes. They found that prediabetes and type 2 diabetes—but not obesity alone—were associated with significantly elevated circulating BAs, a shift toward secondary BAs, and an increased ratio of glycine- to taurine-conjugated BAs. Using in silico community metabolism modeling, they identified diabetes-linked alterations in microbial pathways involving membrane and polyamine synthesis, as well as increased bacterial cross-feeding of polyamines, galactose, and D-arabinose. Serum metabolome data validated several of these predicted microbial exchanges, particularly in amino acid metabolism, suggesting bile acid metabolism as a promising therapeutic target for prediabetes and T2D.
Detailed Summary
Bile acids (BAs) are increasingly recognized as endocrine signaling molecules that regulate glucose, lipid, and energy metabolism through receptors like FXR and TGR5. Despite growing interest, prior studies on how obesity and type 2 diabetes (T2D) affect circulating BA profiles have yielded conflicting results, often due to small sample sizes or failure to separate the effects of obesity from glycemic status. This study aimed to resolve that ambiguity with a large, well-characterized cohort and multi-omics analysis.
The study enrolled 492 adults from the Food Chain Plus (FoCus) cohort, stratified both by BMI (underweight, normal weight, obese) and glycemic status (healthy, prediabetic, diabetic). Nine individual BAs were measured in fasting serum using LC-MS. Gut microbiome composition was assessed via 16S rRNA sequencing (V1-V2 region), and untargeted serum and urine metabolomics was performed using high-resolution mass spectrometry. Critically, in silico genome-scale metabolic network modeling was applied to predict microbial community metabolism—including both microbe-microbe and microbe-host metabolic exchanges—using the Human Reference Gut Microbiome (HRGM) database.
The central finding was that prediabetes and T2D, but not obesity alone, were associated with higher total circulating BAs, a shift toward secondary BAs (produced by gut bacteria), and an elevated glycine-to-taurine BA conjugation ratio. Interestingly, within each metabolic group, the proportion of taurine conjugation varied by BA species: cholic acid (CA) showed a consistently higher fraction of taurine conjugation compared to CDCA and DCA, regardless of metabolic status. A secondary longitudinal cohort of bariatric surgery and formula diet patients further contextualized these findings.
Microbiome analysis revealed that microbial composition changes were associated with BA levels independently of diabetes or obesity status. In silico community metabolism modeling identified differential relative pathway abundance in diabetic versus non-diabetic individuals, particularly in pathways related to membrane biosynthesis and polyamine synthesis. Notably, increased bacterial cross-feeding of polyamines, galactose, and D-arabinose coincided with elevated BA levels. Serum metabolomics validated several of these computationally predicted microbial metabolic exchanges, especially in amino acid metabolism pathways, lending real-world credibility to the modeling approach.
These findings suggest that disrupted BA metabolism in prediabetes and T2D is closely intertwined with specific gut microbial functional shifts, not simply driven by excess adiposity. Targeting BA metabolism—through dietary, pharmacological, or microbiome-directed interventions—may represent a viable therapeutic strategy, especially for early-stage glycemic dysfunction. Caveats include the cross-sectional design of the primary cohort and the use of only 9 measured BAs, which may not capture the full BA spectrum.
Key Findings
- Prediabetes and T2D, but not obesity alone, significantly elevated total circulating bile acids and shifted profiles toward secondary BAs.
- Glycine-to-taurine BA conjugation ratio increased with worsening glycemic status across all three primary BA species.
- Cholic acid consistently showed a higher fraction of taurine conjugation than CDCA or DCA, independent of metabolic phenotype.
- In silico microbial community modeling identified increased polyamine and membrane synthesis pathways associated with diabetes and elevated BAs.
- Serum metabolomics validated in silico predictions, particularly confirming altered amino acid metabolism linked to microbial cross-feeding.
Methodology
Cross-sectional analysis of 492 adults from the FoCus cohort using LC-MS bile acid quantification, 16S rRNA gut microbiome profiling, and high-resolution untargeted metabolomics. Genome-scale metabolic network modeling via the HRGM database predicted microbial community metabolism and host-microbe metabolite exchanges, validated against measured serum metabolome data.
Study Limitations
The primary analysis is cross-sectional, limiting causal inference between bile acid changes and metabolic disease progression. Only 9 of the many known bile acid species were measured, potentially missing important contributors to the overall BA pool. The in silico community metabolism models are predictive and require further experimental validation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.